Comparison of Co2 Laser Versus Co2 Laser With PRP in Scars
Comparative Study on the Efficacy of Fractional CO2 and Fractional CO2 Laser With Autologous Platelet Rich Plasma in Scars
1 other identifier
interventional
60
1 country
1
Brief Summary
Objective: To compare the effect of Fractional Carbon dioxide Laser (FCL) Vs Fractional Carbon dioxide Laser with platelet rich plasma (PRP) in management of Scars. Study design: Randomized-controlled trial (RCT). Study setting and duration: Dermatology Department, CMH-Abbottabad, November 2022/April 2023. Methodology: The sample size of 60 patients, age 18 to 50 years, was calculated by using Openepi app and the non-probability consecutive sampling technique was used. Patient in group A received FCL treatment's four sessions with four weeks apart, whereas Group B received four PRP and FCL sessions. The Quartile grading scale (score 0 is \<25%, score 1 is 25-50%, score 2 is 51-75% and score 3 is \>75% improvement) was used to assess the patient's clinical improvement at 4 weeks after each session. To determine statistical significance χ2-square test, taking p-value \<0.05 as significant, was used.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_1
Started Nov 2022
Shorter than P25 for phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2023
CompletedFirst Submitted
Initial submission to the registry
May 16, 2023
CompletedFirst Posted
Study publicly available on registry
June 2, 2023
CompletedJune 2, 2023
May 1, 2023
6 months
May 16, 2023
May 31, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Quartile grading scale for assessment of scars
Quartile grading scale was used to assess effectiveness of CO2 laser and CO2 laser with Platelet rich plasma in scars.Minimum score=0,Maximum Score=3 .Maximum score means better outcome.The Quartile grading scale (score 0 is \<25%, score 1 is 25-50%, score 2 is 51-75% and score 3 is \>75% improvement) was used to assess the patient's clinical improvement at 4 weeks after each session.
16 weeks
Study Arms (2)
Fractional Co2 laser
ACTIVE COMPARATORPatient in group A received FCL treatment's four sessions four weeks apart.
Platelet Rich Plasma
ACTIVE COMPARATORGroup B received fractional CO2 with four Platelet Rich Plasma sessions,4 weeks apart.
Interventions
Patient in group A received FCL treatments four sessions with four weeks apart
Group B received four PRP and FCL sessions 4 weeks apart
Eligibility Criteria
You may qualify if:
- Patients aged 18-50 years
- Fitzpatrick skin type III-V
- Presented with post-acne, post traumatic or post burn scars
- all those patients emotionally balanced with realistic expectations were included in the study.
You may not qualify if:
- scar that was less than 6 months old
- if they had an active infection or inflammatory skin condition
- having a history of malignancy
- a known connective tissue illness
- history of excessive bleeding or keloids
- unrealistic expectations
- pregnant or breastfeeding.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Dr.Zahra Nigar
Abbottabad, KPK, 22010, Pakistan
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principle Investigator
Study Record Dates
First Submitted
May 16, 2023
First Posted
June 2, 2023
Study Start
November 1, 2022
Primary Completion
April 30, 2023
Study Completion
April 30, 2023
Last Updated
June 2, 2023
Record last verified: 2023-05